| St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment |
32 |
| AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2019 |
19 |
| Granulomatous Mastitis: A Therapeutic and Diagnostic Challenge |
15 |
| AGO Recommendations for the Diagnosis and Treatment of Patients with Locally Advanced and Metastatic Breast Cancer: Update 2019 |
14 |
| Physical Activity, Exercise and Breast Cancer - What Is the Evidence for Rehabilitation, Aftercare, and Survival? A Review |
11 |
| Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries |
10 |
| AGO Recommendations for the Diagnosis and Treatment of Patients with Early Breast Cancer: Update 2018 |
9 |
| Explorative Analysis of Low-Dose Metronomic Chemotherapy with Cyclophosphamide and Methotrexate in a Cohort of Metastatic Breast Cancer Patients |
8 |
| Intraoperative Electron Radiotherapy (IOERT) in the Treatment of Primary Breast Cancer |
8 |
| New Technologies for Sentinel Lymph Node Detection |
8 |
| The Role of Immune Escape and Immune Cell Infiltration in Breast Cancer |
7 |
| AGO Recommendations for the Diagnosis and Treatment of Patients with Advanced and Metastatic Breast Cancer: Update 2018 |
7 |
| Evaluating the Demand for Integrative Medicine Practices in Breast and Gynecological Cancer Patients |
6 |
| Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial |
6 |
| Is Axillary Sentinel Lymph Node Biopsy Required in Patients Who Undergo Primary Breast Surgery? |
6 |
| Why Do Women with Breast Cancer Get Diagnosed and Treated Late in Sub-Saharan Africa? Perspectives from Women and Patients in Bamako, Mali |
5 |
| Modifiable Lifestyle Factors: Opportunities for (Hereditary) Breast Cancer Prevention - a Narrative Review |
5 |
| Management of Adverse Events Due to Cyclin-Dependent Kinase 4/6 Inhibitors |
5 |
| Recent Developments in Radiation Oncology: An Overview of Individualised Treatment Strategies in Breast Cancer |
5 |
| Proton Therapy for Primary Breast Cancer |
5 |
| Current Status and Future Perspectives of Axillary Management in the Neoadjuvant Setting |
5 |
| Individualized eHealth Support for Oncological Therapy Management |
4 |
| What Is the Best Management of cN0pN1(sn) Breast Cancer Patients? |
4 |
| Granulomatous Lobular Mastitis: Antituberculous Treatment and Outcome in 22 Patients |
4 |
| Treatment of Early Breast Cancer Patients: Evidence, Controversies, Consensus: Focusing on Systemic Therapy - German Experts' Opinions for the 16th International St. Gallen Consensus Conference (Vienna 2019) |
4 |
| TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients - First Results on the Influence of Tumor-Infiltrating Lymphocytes |
4 |
| Checkpoint Inhibitors in Breast Cancer - Current Status and Future Directions |
3 |
| ABC4 Consensus: Assessment by a German Group of Experts |
3 |
| Does Exercise Have a Preventive Effect on Secondary Lymphedema in Breast Cancer Patients Following Local Treatment? - A Systematic Review |
3 |
| Intraductal Papilloma Without Atypia on Image- Guided Breast Biopsy: Upgrade Rates to Carcinoma at Surgical Excision |
3 |
| Axillary Web Syndrome in Breast Cancer: A Prevalent But Under-Recognized Postoperative Complication |
3 |
| Using a New Marker Clip System in Breast Cancer: Tumark Vision (R) Clip - Feasibility Testing in Everyday Clinical Practice |
3 |
| Can Nutrition Lower the Risk of Recurrence in Breast Cancer? |
3 |
| Biosimilar Trastuzumab in Clinical Trials: Differences or Not? |
3 |
| Position of Scientific Oncological Societies Towards Biosimilar Antibodies |
2 |
| Early-Onset Breast Cancer: Effect of Diagnosis and Therapy on Fertility Concerns, Endocrine System, and Sexuality of Young Mothers in Germany |
2 |
| European Guidelines on the Organisation of Breast Centres and Voluntary Certification Processes |
2 |
| National Breast Screening Programs across Europe |
2 |
| Surgical Management of Breast Cancer Treated with Neoadjuvant Therapy |
2 |
| Primary Rhabdomyosarcoma of the Breast: Imaging Findings and Literature Review |
2 |
| The Role of Brachytherapy in the Treatment of Breast Cancer |
2 |
| Nipple-Sparing Mastectomy with Primary Implant Reconstruction: Surgical and Oncological Outcome of 435 Breast Cancer Patients |
2 |
| Benign Breast Tumours - Diagnosis and Management |
2 |
| Clinical Validation of PITX2 DNA Methylation to Predict Outcome in High-Risk Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy |
2 |
| Predictive Factors for Non-Sentinel Lymph Node Metastasis in Patients with ACOSOG Z0011 Criteria |
2 |
| Adjuvant Dose-Dense Chemotherapy for Breast Cancer: Available Evidence and Recent Updates |
2 |
| Local Control of Breast Conservation Therapy versus Mastectomy in Multifocal or Multicentric Breast Cancer: A Systematic Review and Meta-Analysis |
2 |
| Effect of LigaSure (TM), Monopolar Cautery, and Bipolar Cautery on Surgical Margins in Breast-Conserving Surgery |
2 |
| Effectiveness and Safety of Implant-Based Breast Reconstruction in Locally Advanced Breast Carcinoma: A Matched Case-Control Study |
2 |
| Dystrophic Calcifications in the Breast from Secondary Hyperparathyroidism |
1 |
